Brainomix Company

Brainomix has developed automated medical software for stroke image analysis, and lung diseases such as NSCLC and IPF. Our Radiology AI biomarkers enable precision medicine for better treatment.

Connections from

Estimated Revenue: $33.16M
Funding Status: Early Stage Venture
Headquarters: Oxford, Oxfordshire, United Kingdom
Total Funding: 35017490
Last Funding Date: 2021-12-16
Investors Number: 6
Number Of Exists: 11-50
Founded Date: 2010-01-01
Industry: Aging Biomarkers
Last Funding Type: Series B
Employee Number: 9